Current Report Filing (8-k)
May 11 2021 - 6:42AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 11, 2021
InspireMD, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-35731
|
|
26-2123838
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
4 Menorat Hamaor St.
Tel Aviv, Israel
|
|
6744832
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(888) 776-6804
(Registrant’s telephone number, including area
code)
N/A
(Former Name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of exchange on
which registered
|
Common Stock, par value $0.0001 per share
|
|
NSPR
|
|
NYSE American
|
Warrants, exercisable for one share of Common Stock
|
|
NSPR.WS
|
|
NYSE American
|
Series B Warrants, exercisable for
one share of Common Stock
|
|
NSPR.WSB
|
|
NYSE American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 2.02 Results of Operations and Financial Condition.
On May 11, 2021, InspireMD, Inc.
issued a press release announcing its financial and operating results and recent highlights for the first quarter ended March 31, 2021.
A copy of that press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instruction
B.2 of Form 8-K, the information in this Current Report on Form 8-K that is furnished pursuant to this Item 2.02 shall not be deemed to
be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or
other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
InspireMD, Inc.
|
|
|
|
Date: May 11, 2021
|
By:
|
/s/ Craig Shore
|
|
Name:
|
Craig Shore
|
|
Title:
|
Chief Financial Officer
|
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Mar 2024 to Apr 2024
InspireMD (AMEX:NSPR)
Historical Stock Chart
From Apr 2023 to Apr 2024